The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL

INTRODUCTION: In previous studies, protease inhibitor (PI) monotherapy has shown trends for higher low-level elevations in HIV-1 RNA compared to triple therapy, but no increase in the risk of drug resistance. METHODS: A total of 273 patients with HIV-1 RNA <50 copies/mL for over 24 weeks on curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Antinori, Andrea, Arribas, Jose, Fehr, Jan, Girard, Pierre-Marie, Horban, Andrzej, Hill, Andrew, van Delft, Yvon, Moecklinghoff, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Oral Presentation – Abstract O423A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224888/
https://www.ncbi.nlm.nih.gov/pubmed/25394034
http://dx.doi.org/10.7448/IAS.17.4.19525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224888/
https://www.ncbi.nlm.nih.gov/pubmed/25394034
http://dx.doi.org/10.7448/IAS.17.4.19525

Ejemplares similares